Menu

Latest news & events

Professorship Julie Staals

Professorship Julie Staals

22 April 2024

Dr Julie Staals (Dept. of Neurology) has been appointed as professor 'Neurovascular disease' as of 1 April 2024.

Read more
ERC Advanced Grant awarded to Prof. Andy Baker

ERC Advanced Grant awarded to Prof. Andy Baker

15 April 2024

Prof. Andy Baker (Dept of Pathology) has been awarded a European Research Council (ERC) Advanced Grant of €2,5M for his research project PolymiRize: Poly-miRNA targeting to prevent and reverse complex tissue remodelling after acute cardiovascular events'.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Miranda Schram

Professor

Dr Miranda Schram holds a MSc in Biomedical Sciences (1999) and in Epidemiology (2002). She recieved her PhD entitled 'Patophysiology of diabetic complications, arterial stiffness, endothelial dysfunction and inflammation' at VU University Medical Center in Amsterdam in 2004, and is a registered Epidemiologist B. She has worked as post-doc epidemiologist at Erasmus MC in Rotterdam, at Leiden University Medical Center and as senior investigator at the National Institute for Public Health and the Environment in Bilthoven. From 2008 onwards, she has been working at Maastricht UMC+ as senior investigator at The Maastricht Study.

Miranda Schram is one of the founders of The Maastricht Study, a novel population-based cohort study on type 2 diabetes and its complications. Her scientific work focusses on the etiology and epidemiology of cognitive decline and depression in type 2 diabetes with a specific interest in the role of early vascular dysfunction. A second research line focusses on psychosocial aspects of diabetes, to understand how social networks, but also ethnicity and diabetes distress can affect diabetes treatment and the development of complications. Miranda is board member of The Maastricht Study, coordinator of the Dutch Diabetes Pearlstring Initiative, active member of the PSAD study group of the EASD and involved in the Netherlands Consortium of Demetia Cohorts.

Miranda-schram

Department of Internal Medicine
Randwycksingel 35, 6229 EG Maastricht
T: +31(0)6 122 64 289

  • 2012
    • Muris, D. M. J., Houben, A. J. H. M., Schram, M. T., & Stehouwer, C. D. A. (2012). Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus A Systematic Review and Meta-Analysis. Arteriosclerosis Thrombosis and Vascular Biology, 32(12), 3082-3094. https://doi.org/10.1161/ATVBAHA.112.300291
    • Van't Riet, E., Schram, M. T., Abbink, E. J., Admiraal, W. M., Dijk-Schaap, M. W., Holleman, F., Nijpels, G., Ozcan, B., Pijl, H., Schaper, N. C., Sijbrands, E. J. G., Silvius, B., Tack, C. J., de Valk, H. W., Wolffenbuttel, B. H. R., Stehouwer, C. D. A., & Dekker, J. M. (2012). The Diabetes Pearl: Diabetes biobanking in The Netherlands. BMC Public Health, 12, 949. https://doi.org/10.1186/1471-2458-12-949
  • 2007
    • Schram, M. T., Euser, S. M., Craen, A. J., Witteman, J. C. M., Frolich, M., Hofman, A., Jolles, J., Breteler, M. M., & Westendorp, R. G. J. (2007). Systemic markers of inflammation and cognitive decline in old age. Journal of the American Geriatrics Society, 55 (5), 708-16. https://doi.org/10.1111/j.1532-5415.2007.01159.x
  • 2006
    • Schalkwijk, C. G., Chaturverdi, N., Schram, M. T., Fuller, J. H., & Stehouwer, C. D. A. (2006). Re: Adiponectin and renal function: pitfalls of renal function estimates and corrections for BSA. Journal of Clinical Endocrinology & Metabolism.
  • 2005
    • Schram, M. T., Schalkwijk, C. G., Bootsma, A. H., Fuller, J. H., Chaturvedi, N., & Stehouwer, C. D. (2005). Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension, 46(1), 232-237. https://doi.org/10.1161/01.HYP.0000164574.60279.ba
    • Schram, M. T., van Ittersum, F. J., Spoelstra-de Man, A. M., van Dijk, R. A. J. M., Schalkwijk, C. G., Ijzerman, R. G., Twisk, J. W. R., & Stehouwer, C. D. A. (2005). Aggressive antihypertensive therapy based on hydrochlorothiazide candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals effects on albumin excretion endothelial function and inflammation in a double-blind randomized cl. Journal of Human Hypertension, 19, 429-437. https://doi.org/10.1038/sj.jhh.1001812
    • Schram, M. T., & Stehouwer, C. D. (2005). Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Hormone and Metabolic Research, 37 Suppl 1, 49-55. https://doi.org/10.1055/s-2005-861363
    • Schram, M. T., Chaturvedi, N., Schalkwijk, C. G., Fuller, J. H., Stehouwer, C. D. A., & EURODIAB ProspectivE Compl.St., G. (2005). Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia, 48(2), 370-378. https://doi.org/10.1007/s00125-004-1628-8
Overview